Vericel
NasdaqGM:VCEL Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 4 Fair Values set on narratives written by author
AN
Consensus Narrative from 8 Analysts
FDA Approvals And Global Expansion Will Advance Adoption Of MACI Arthro And NexoBrid
Key Takeaways FDA approval for MACI Arthro and increasing surgeon adoption signal significant potential for future revenue growth and market expansion. International expansion efforts and reduced capital expenditures aim to enhance scalability, potentially boosting operating cash flow and earnings.
View narrativeUS$65.38
FV
29.2% undervalued intrinsic discount24.04%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
2 days ago author updated this narrative